- Trump’s 200% generic tariff threat would imperil Americans: Indian pharma The Hindu
- Donald Trump tariff plan puts Indian generic drug exports to US under pressure Telegraph India
- Trump’s 200% tariff plan may be a bitter pill for US consumers; Dr Reddy’s warns of costlier medicines The Times of India
- Trump’s threat of 200% tariffs on generic drugs a major danger for India’s pharma industry Deccan Herald
- Trump’s 100% Generic Drug Duty Threatens US Low-Cost Supply Bloomberg.com